NASDAQ
$1.26
(0.73%)
Subscribe to get
AI Score
On Sunday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced multiple program updates,...
Green Alpha Advisors LLC lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing ...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte...
In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement...
One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Believe it or not,...
ClearBridge Investments, an investment management company, released its “ClearBridge Growth...
ORG Partners LLC boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 108.2% during the fourth quarter, according to its most recent Form 13F ...
Zai Lab (ZLAB) and Vertex Pharmaceuticals (VRTX) announced an exclusive collaboration and license...
Vertex Pharmaceuticals Inc (VRTX, Financial) has released a comprehensive update on its various programs as it prepares for upcoming investor meetings, including a webcast at the 43rd Annual ...
Vertex Pharmaceuticals Inc (VRTX, Financial) has entered into an exclusive collaboration and license agreement with Zai Lab Limited for the development and commercialization of Vertex's povetacicept ...